Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by MrMugsyon Jun 10, 2022 11:25am
162 Views
Post# 34747175

It warms the cockles of my heart ...

It warms the cockles of my heart ...It warms the cockles of my heart to see ENDO's stock price at almost zero.

Not because I wish them any harm ... but ... it's about time that the market sees them for what they really are - for all the mistakes they made.  Funny that investors were proping this thing up for years yet there was no basis for doing that.  The troubles were obvious and the real pain is yet to come.

Well - it gave invested shareholders more than enough time to exit and limiting their losses while others were left to hold the bag.  What a soap opera.  Looking forward to the restructuring to see how that plays out - think discussions are well underway.

I still remember when Goodman made comment to Endo's debt-laden approach and how it would eventually hurt them.  Still rings loud in my ear.

And so here we are ... man ... I think Endo's CEO learned early not to like Goodman for that honesty.  Hahaha!  Just love it !!!!
<< Previous
Bullboard Posts
Next >>